Evidence map›Paper›PMID 39812873›Full record

ArticleJournal of clinical immunology2025

Hypomorphic RAG2 Deficiency Promotes Selection of Self-Reactive B Cells.

Christopher D Thouvenel, Christopher M Tipton, Yasuhiro Yamazaki, Ting-Ting Zhang, Stacey Rylaarsdam, Jennifer R Hom, Catherine Snead, Chengsong Zhu, Quan-Zhen Li, Yu Nee Lee and 12 more

Abstract read
In one paragraph

Article in Journal of clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Christopher D ThouvenelCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA.
Christopher M TiptonLowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA, USA.
Yasuhiro YamazakiLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Ting-Ting ZhangCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA.
Stacey RylaarsdamCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA.
Jennifer R HomLowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA, USA.
Catherine SneadImmunome Inc, Bothell, WA, USA.
Chengsong ZhuDepartment of Immunology, Microarray and Immune Phenotyping Core, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Quan-Zhen LiGenecopia Inc, Rockville, MD, USA.
Yu Nee LeePediatric Department A and the Immunology Service, Ramat-Gan and Sackler Faculty of Medicine, "Edmond and Lily Safra" Children's Hospital, Jeffrey Modell Foundation Center, Sheba Medical Center, Tel Hashomer, Tel-Aviv University, Tel-Aviv, Israel.
Tomoki KawaiLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Neshatul HaqueBioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Michael T ZimmermannBioinformatics Research and Development Laboratory, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Sivasankaran Munusamy PonnanCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA.
Shaun W JacksonCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA.
Rich G JamesCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA.
Ignacio SanzLowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA, USA.
Luigi D NotarangeloLaboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Troy R TorgersonAllen Institute for Immunology, Seattle, WA, USA.
Hans D OchsCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA.
David J RawlingsCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA. drawlings@uw.edu.
Eric J AllenspachCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA, USA. eric.allenspach@seattlechildrens.org.

Funding

Regulation of B cell Responses in SLE and Other Autoimmune DiseasesU19AI110483 · NIAID · EMORY UNIVERSITY · PI Ignacio E. Sanz · 2014 to 2026
$76.6M
Role of B Cells in Synovial Inflammation & LN Remodeling in RA ArthritisP01AI078907 · NIAID · UNIVERSITY OF ROCHESTER · PI LUND, FRANCES E. · 2010 to 2014
$10.8M
Mechanistic insights into systemic lupus erythematosus (SLE) pathogenesis from inborn errors of immunityR01AR073938 · NIAMS · SEATTLE CHILDREN'S HOSPITAL · PI Shaun William Jackson · 2019 to 2026
$4.0M
Impact of Loss-of-function NADPH Oxidase Variants on B-Cell Activation in SLER01AR075813 · NIAMS · SEATTLE CHILDREN'S HOSPITAL · PI JACKSON, SHAUN WILLIAM · 2021 to 2025
$2.8M
Interrogating The Biology Of Human Lupus Nephritis Using Single Cell Resolution Spatial TranscriptomicsR01DK136980 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Shaun William Jackson · 2024 to 2026
$2.5M
Mentoring the next generation of researchers in pediatric autoimmunityK24AR085177 · NIAMS · SEATTLE CHILDREN'S HOSPITAL · PI Shaun William Jackson · 2025 to 2026
$424k
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2R03TR004589 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI ZIMMERMANN, MICHAEL T · 2023 to 2023
$156k
NCATS NIH HHS R03 TR004589NIAID NIH HHS P01 AI078907NIAID NIH HHS U19 AI110483NIAMS NIH HHS K24 AR085177NIAMS NIH HHS R01 AR073938NIAMS NIH HHS R01 AR075813NIDDK NIH HHS R01 DK136980
6 · The paper itself

Abstract

Reduced function or hypomorphic variants in recombination-activating genes (RAG) 1 or 2 result in a broad clinical phenotype including common variable immunodeficiency (CVID) and even adult-onset disease. Milder RAG variants are less characterized. Here we describe the longitudinal course of a milder combined RAG deficiency in 3 of 7 siblings sharing the same RAG2 mutations over a 50-year study. Whole-genome and repertoire sequencing, bacteriophage immunizations, and deep immunophenotyping were used to compare affected and unaffected family members. The clinical phenotype of three affected siblings with hypomorphic RAG deficiency ranged from combined immunodeficiency and early mortality to a late-onset CID with hyper-IgM phenotype. T cells were remarkably similar across affected siblings, yet CDR3 skewing and regulatory T cell defects were not observed. B cell analysis showed elevated unswitched CD27+ and CD21

Indexed as

B-LymphocytesDNA-Binding ProteinsAdultAutoimmunityChildChild, PreschoolFemaleHumansImmunophenotypingMaleMutationNuclear ProteinsPedigreePhenotypeSiblingsDNA-Binding ProteinsNuclear ProteinsRAG2 protein, humanHyper-IgMHypomorphic RAG deficiencyMarginal zone B cellVH4-34

Identifiers

PMID39812873
PMCPMC11735530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.